Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 117.58 USD -0.06%
Market Cap: 204.6B USD
Have any thoughts about
Abbott Laboratories?
Write Note

Abbott Laboratories
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbott Laboratories
Capital Expenditures Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Capital Expenditures
-$2.2B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Becton Dickinson and Co
NYSE:BDX
Capital Expenditures
-$723m
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
-2%
Boston Scientific Corp
NYSE:BSX
Capital Expenditures
-$780m
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
-10%
Edwards Lifesciences Corp
NYSE:EW
Capital Expenditures
-$327.6m
CAGR 3-Years
2%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Stryker Corp
NYSE:SYK
Capital Expenditures
-$634m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Intuitive Surgical Inc
NASDAQ:ISRG
Capital Expenditures
-$1.2B
CAGR 3-Years
-67%
CAGR 5-Years
-29%
CAGR 10-Years
-33%

See Also

What is Abbott Laboratories's Capital Expenditures?
Capital Expenditures
-2.2B USD

Based on the financial report for Sep 30, 2024, Abbott Laboratories's Capital Expenditures amounts to -2.2B USD.

What is Abbott Laboratories's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-7%

Over the last year, the Capital Expenditures growth was -9%. The average annual Capital Expenditures growth rates for Abbott Laboratories have been -5% over the past three years , -6% over the past five years , and -7% over the past ten years .

Back to Top